Workflow
芬塔(VTR)
icon
搜索文档
Here's Why You Should Retain Ventas (VTR) in Your Portfolio
ZACKS· 2024-07-11 00:51
Over the past month, shares of this Zacks Rank #3 (Hold) company have risen 5.4% compared with the industry's upside of 1.8%. Competition from national and local healthcare operators may weigh on Ventas. The company's operators contend with peers for occupancy, which could limit its power to raise rents and drive profitability, as well as crack deals at attractive rates. Stocks to Consider The Zacks Consensus Estimate for Paramount Group's 2024 FFO per share has been raised marginally over the past month to ...
Ventas(VTR) - 2024 Q1 - Quarterly Report
2024-05-03 04:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM____________TO____________ Commission file number: 1-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State or Ot ...
Ventas(VTR) - 2024 Q1 - Earnings Call Presentation
2024-05-03 01:33
VENTAS® Earnings Presentation First Quarter 2024 Non-GAAP Financial Measures & Cautionary Statements Non-GAAP Financial Measures This presentation includes certain financial performance measures not defined by generally accepted accounting principles in the United States ("GAAP"), such as Nareit FFO, Normalized FFO, Net Operating Income ("NOI"), Same-Store Cash NOI, Same-Store Cash NOI Margin, Same-Store Cash NOI Growth and Net Debt to Further Adjusted EBITDA. Reconciliations of these non-GAAP financial mea ...
Ventas(VTR) - 2024 Q1 - Earnings Call Transcript
2024-05-03 01:31
Ventas, Inc. (NYSE:VTR) Q1 2024 Earnings Conference Call May 2, 2024 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & CIO Robert Probst - EVP & CFO Conference Call Participants James Kammert - Evercore Michael Carroll - RBC Capital Markets Michael Griffin - Citi Nicholas Joseph - Citi Omotayo Okusanya - Deutsche Bank Juan Sanabria - BMO Capital Markets Ronald Kamdem - Morgan Stanley Joshua Dennerlein - Bank of America Nicholas Yulico ...
Ventas(VTR) - 2024 Q1 - Quarterly Results
2024-05-02 04:17
Exhibit 99.1 Ventas, Inc. 353 North Clark Street, Suite 3300 Chicago, Illinois 60654 (877) 4-VENTAS www.ventasreit.com Contact: BJ Grant (877) 4-VENTAS Ventas Reports 2024 First Quarter Results CHICAGO – (BUSINESS WIRE) – Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the first quarter ended March 31, 2024. CEO Remarks “2024 is off to a strong start, led by continued organic growth in our advantaged senior housing operating portfolio (“SHOP”), as we execute against our strat ...
Ventas(VTR) - 2023 Q4 - Annual Report
2024-02-16 06:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 1-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State or Other Jurisdiction of Incorporation o ...
Ventas(VTR) - 2023 Q4 - Earnings Call Transcript
2024-02-16 04:55
Ventas, Inc. (NYSE:VTR) Q4 2023 Earnings Conference Call February 15, 2024 1:00 PM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & CIO Robert Probst - EVP & CFO Peter Bulgarelli - EVP, Outpatient Medical & Research Conference Call Participants Michael Mueller - JPMorgan Chase & Co. Nicholas Joseph - Citigroup Richard Anderson - Wedbush Securities Ronald Kamdem - Morgan Stanley Connor Siversky - Wells Fargo Securities Juan Sanabria - BMO Capi ...
Ventas(VTR) - 2023 Q3 - Quarterly Report
2023-11-04 03:52
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM____________TO____________ Commission file number: 1-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State o ...
Ventas(VTR) - 2023 Q3 - Earnings Call Transcript
2023-11-04 01:41
Ventas, Inc. (NYSE:VTR) Q3 2023 Earnings Conference Call November 3, 2023 10:00 AM ET Company Participants BJ Grant - SVP, IR Debra Cafaro - Chairman and CEO Justin Hutchens - CIO and EVP, Senior Housing Bob Probst - EVP and CFO Pete Bulgarelli - EVP and President and CEO, Lillibridge Healthcare Services, Inc. Conference Call Participants Austin Wurschmidt - KeyBanc Capital Markets Steve Sakwa - Evercore ISI Nick Joseph - Citi Juan Sanabria - BMO Capital Markets Mike Mueller - JPMorgan Ronald Kamdem - Morga ...
Ventas(VTR) - 2023 Q3 - Earnings Call Presentation
2023-11-03 22:33
November 2, 2023 Earnings Presentation Third Quarter 2023 Non-GAAP Financial Measures & Cautionary Statements 2 Certain of the information contained herein, including certain operating and clinical information, such as patient and resident pricing and rate information, lead and move-in data and number of confirmed cases of COVID-19, has been provided by our operators and we have not verified this information through an independent investigation or otherwise. We have no reason to believe that this informatio ...